Introducing new and emerging genetic tests into prenatal care

Area of Science:

• Genomics
• Prenatal Diagnostics
• Clinical Genetics

Background:

• Genomic technologies are advancing rapidly, presenting challenges in their clinical integration.
• Effective translation of novel genomic tests into prenatal care requires careful consideration.

Purpose of the Study:

• To discuss emerging prenatal genetic tests and their clinical implementation.
• To outline the roles of various stakeholders in introducing new prenatal genetic tests.
• To emphasize the importance of data sharing for clinical and scientific advancement.

Main Methods:

• Review of emerging genetic tests and their validation requirements.
• Discussion of regulatory pathways and stakeholder involvement (FDA, CLIA, commercial labs, insurers, professional societies like ACOG and SMFM).
• Emphasis on post-implementation data collection and analysis.

Main Results:

• The introduction of new prenatal genetic tests necessitates a multifaceted approach involving validation, regulatory oversight, and stakeholder collaboration.
• Shared databases with measured outcomes are essential for refining clinical practice and advancing scientific understanding.

Conclusions:

• Successful integration of advanced genomic testing in prenatal care depends on rigorous validation and coordinated efforts.
• Continuous data sharing and outcome measurement are vital for improving patient care and driving scientific progress in prenatal genomics.